Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Freight Technologies announced significant progress in transforming into a software-first, AI-native logistics technology company, focusing on scaling its AI-powered platforms like Fleet Rocket, Zayren, and Fr8Radar. The company is exploring strategic alternatives for its traditional brokerage operations to concentrate resources on its AI software …
Scorpio Tankers Inc. has entered into a strategic collaboration with AMPERA, Inc. to jointly develop and commercialize advanced micronuclear power solutions aimed at powering maritime vessels, offshore, and port infrastructure with zero carbon emissions. The collaboration focuses on deploying ultra-safe micro nuclear reactors, including floating nu…
Transocean Ltd. announced $1 billion in new and extended offshore drilling contracts spanning Norway and Brazil, along with the early retirement of $358 million in senior secured notes. These developments strengthen the company's backlog, reduce interest expenses, and support its deleveraging strategy.
Burning Rock Biotech Limited announced that founder, chairman, and CEO Yusheng Han purchased 31,487 American Depositary Shares (ADSs) for $546,603.90 on the open market, adding to prior purchases this year. These transactions signal strong insider confidence in the company's precision oncology business, which focuses on next generation sequencing (…
Global Net Lease, Inc. announced that board members Sue Perrotty and Governor Edward Rendell will retire following the 2026 Annual Meeting of Stockholders, reducing the board size to eight members. The company acknowledges their contributions, particularly during the 2023 merger and internalization process.
Acuity Inc. delivered a robust second-quarter fiscal 2026 performance marked by 5% net sales growth to $1.1 billion, 21% increase in operating profit to $133 million, and a 26% rise in diluted EPS to $3.09. The company's two business segments had mixed results: Acuity Brands Lighting sales slightly declined by 2.8%, while Acuity Intelligent Spaces …
Roivant Sciences announced the expansion of its brepocitinib development program to include a new seamless Phase 2b/3 clinical trial for the inflammatory scalp disorder lichen planopilaris (LPP), which currently has no FDA-approved treatments. Concurrently, Roivant reported topline results from Immunovant's Phase 3 studies of batoclimab in thyroid …
Priovant Therapeutics announced the initiation of a seamless Phase 2b/3 clinical trial for brepocitinib in treating Lichen Planopilaris (LPP), a severe inflammatory scalp disorder with no FDA-approved treatments. This marks the fourth indication in brepocitinib's late-stage development alongside dermatomyositis, non-infectious uveitis, and cutaneou…
Futu Holdings Limited, a Nasdaq-listed online brokerage and wealth management platform, declared a cash dividend of $0.325 per ordinary share (equivalent to $2.6 per American Depositary Share), totaling approximately $365 million, payable to shareholders as of April 16, 2026, with payment expected around April 29, 2026.
Immunovant announced that its Phase 3 clinical trials for batoclimab in treating thyroid eye disease (TED) failed to meet their primary efficacy endpoint. While safety profiles were consistent with previous results and no new risks identified, the drug did not achieve the targeted proptosis improvement at 24 weeks. The company highlighted promising…
Celldex Therapeutics, a clinical-stage biotechnology company, announced the pricing of an underwritten public offering of 10,345,000 shares at $29.00 per share, expecting gross proceeds of approximately $300 million. The offering aims to fund its commercial readiness and potential launch of barzolvolimab for chronic spontaneous urticaria, continue …
The Bahamian government has announced an early national election for May 12, with Prime Minister Philip Davis scheduling the dissolution of parliament on April 8 and formally calling the vote the next day. The move comes alongside a decision to eliminate value-added tax on unprepared grocery items as officials seek to address a cost-of-living ranke…
Universal Safety Products, Inc. (NASDAQ: UUU) disclosed that director Ault Milton C III purchased shares totaling $72,808 across transactions on March 30 and 31. The company also reported issuing 405,000 shares between January 26 and February 3 as part of a convertible note conversion totaling $1,503,424.80, executed under a Section 4(a)(2) exempti…
A 7-month-old girl riding in a stroller was shot and killed on a Brooklyn street during an apparent gang-related exchange of gunfire. City officials say the child was an unintended target; one suspect has been taken into custody and police continue to seek a second man seen fleeing the scene on a moped.
U.S. officials are preparing to announce tariffs on pharmaceutical companies that have not struck deals to guarantee lower prices domestically, with a potential 100% tariff on imported branded and patented medicines. Some multinational drugmakers have negotiated exemptions by committing to pricing arrangements and U.S. investment, while others have…
Steven S. Fendley, President of Kratos Defense & Security Solutions' U.S. division, sold 6,998 shares of the company's common stock on March 30, 2026, realizing about $487,119. The transactions occurred under a 10b5-1 trading plan adopted May 12, 2025. The move comes as Kratos shares have fallen 15% over the prior week but remain up 131% year-over-…
Globalstar Inc. shares rallied sharply in after-hours trade after reports indicated Amazon is in discussions to acquire the satellite telecommunications company. The stock jumped roughly 16% to $79.70, its highest level since early 2008. Media coverage said the potential deal would bolster Amazon's low Earth orbit satellite ambitions and position i…
MediaAlpha director Steven Yi reported the sale of 12,000 shares of Class A common stock across three trades from March 30 to April 1, 2026, raising $111,907. The transactions, disclosed on a Form 4 filing, were executed under a Rule 10b5-1 trading plan to cover tax liabilities from vested restricted stock units. The company recently posted Q4 2025…
Caddis Holdings, LP, a roughly 10% shareholder in Fermi Inc. (FRMI), disposed of 11,000,000 shares of common stock in two transactions on March 30 and March 31, 2026, generating approximately $56,268,500. The sales occurred as Fermi's shares experienced pronounced volatility, falling 19% over the prior week and 83% over the trailing year. Following…
Realty Income Corp director Gregory McLaughlin sold 3,275 shares on April 1, 2026, for $61.87 apiece, totaling $202,624. The transaction leaves McLaughlin with 34,993 shares held by a family trust. The REIT, with a market value of $57.86 billion and a 5.25% dividend yield, is trading above its InvestingPro Fair Value. Separately, the company priced…
Goldman Sachs reported that global hedge funds endured their worst monthly drawdown since January 2022, driven by market turbulence associated with the Iran war and rapid shifts across rates, currencies, commodities and equity factor rotations. Fundamental long/short stockpickers were broadly negative in March, with Asia-focused managers hit hardes…
Cheniere Energy EVP and CFO Zach Davis sold 29,000 shares of common stock on March 30, 2026, for $300 per share, a transaction valued at $8.7 million. After the sale Davis holds 87,146 shares. Independent valuation commentary cites potential overvaluation versus Fair Value despite a P/E of 11.38. Separately, Cheniere reported strong fourth-quarter …
Tesla director Kathleen Wilson-Thompson sold 20,008 shares on March 30, 2026 for roughly $9.27 million and exercised options to acquire 40,000 additional shares at $14.99 each. The transactions leave her with 47,748 shares directly owned. The moves occur amid divergent analyst price targets and commentary on deliveries and regional demand.
Elena Ridloff, a director at Kymera Therapeutics, sold 12,000 shares of the company's common stock on March 31 and April 1, 2026, for just over $1 million. The transactions, reported on a Form 4 with the SEC, occurred at prices between $85.1946 and $86.05. On those same dates she exercised options to buy 12,000 shares at $14.18 per share. Separatel…
Kymera Therapeutics Chief Operating Officer Jeremy G. Chadwick sold 22,240 shares across March 31 and April 1, 2026, for about $1.9 million, executing trades under a pre-arranged Rule 10b5-1 plan. The transactions coincided with a year of strong stock performance and followed option exercises that acquired the same number of shares at a strike of $…
